Omni Bridgeway Limited (OBL) Fair Value & Analysis
Financial Services · AU · Market cap A$478M
Fair value as of: Jun 26, 2026
Analysis
Omni Bridgeway Limited (OBL) currently trades at A$1.56, while our model-based Fair Value estimate is A$3.12 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 80/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Omni Bridgeway Limited, together with its subsidiaries, provides dispute and litigation finance services in Australia, the United States, Canada, Latin America, Asia, New Zealand, Europe, the Middle East, and Africa. The company offers dispute funding solutions, including bankruptcy, commercial, intellectual property, investor recoveries, class/group actions, appeals, and whistleblower. It also provides arbitration financing, judgment enforcement, and distressed asset recovery solutions. The company serves individual claimants, law firms, corporations, bankruptcy/insolvency professionals, liquidators, banks, creditors, sovereigns, and multilateral institutions. The company was formerly known as IMF Bentham Limited and changed its name to Omni Bridgeway Limited in March 2020. Omni Bridgeway Limited was founded in 1986 and is based in Sydney, Australia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Omni Bridgeway Limited (OBL) undervalued?
What is the fair value of OBL?
What is the quality score of OBL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.